Clinical Nurse Specialist in Springfield, MO Accepting Medicare

11 Clinical Nurse Specialist nurses found. Showing 1 - 11

Glenda Miller, APN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 3801 S National Ave, Springfield, MO 65807 Phone: 417-269-6000    Fax: 417-269-3104

Karen Lee Foster, RNC WHNP Clinical Nurse Specialist - Women's Health Medicare: Not Enrolled in Medicare Practice Location: 626 E Battlefield, Springfield, MO 65807 Phone: 417-883-3800    Fax: 417-883-3994

Margaret Leigh Williams, Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 1235 E Cherokee St, Springfield, MO 65804 Phone: 417-820-6435    Fax: 417-820-9098

Jana D Johnson, NP Clinical Nurse Specialist - Family Health Medicare: Not Enrolled in Medicare Practice Location: 1720 W Battlefield St, Springfield, MO 65807 Phone: 417-881-8649    Fax: 417-881-8765

Ms. Deborah L Horine, APRN Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 1235 E Cherokee St, Springfield, MO 65804 Phone: 417-820-2000

Jacqulynn Poe, Clinical Nurse Specialist - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 3800 S National Ave Ste 400, Springfield, MO 65807 Phone: 417-875-3846

Mrs. Stephanie Marie Hove, ANP-BC Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 2115 S Fremont Ave, Ste 5000, Springfield, MO 65804 Phone: 417-820-3960

Jennifer Wheeler, NNP Clinical Nurse Specialist - Neonatal Medicare: Not Enrolled in Medicare Practice Location: 1235 E Cherokee St, Springfield, MO 65804 Phone: 417-820-2891

Katie Lynn Price, DNP, APRN, ACCNS-AG Clinical Nurse Specialist - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 3801 S National Ave, Springfield, MO 65807 Phone: 417-269-3000

Rebecca A Kahmke, AHCNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 3525 S National Ave Ste 205a, Springfield, MO 65807 Phone: 417-269-9714    Fax: 417-269-9236

Theresa A. Witt, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1900 S National Ave, Suite 3400, Springfield, MO 65804 Phone: 417-820-3960    Fax: 417-820-3966

News Archive

Bacterial cell factories produce enzymes that can be used as active ingredients in drugs

Researchers at the Novo Nordisk Foundation Center for Biosustainability in Denmark have developed a method of producing P450 enzymes - used by plants to defend against predators and microbes - in bacterial cell factories. The process could facilitate the production of large quantities of the enzymes, which are also involved in the biosynthesis of active ingredients of cancer drugs.

Researchers develop method to better measure people's quality of life

A new research method that quantifies people's quality of life - beyond how much money they make - could lead to a national index of well-being, similar to key measures of economic health.

Algos Therapeutics changes name to Algos Preclinical Services

Following a shift in its business model from developing proprietary pain therapy products to pure contract research, Algos Therapeutics has changed its name to Algos Preclinical Services. The company's new tagline, "Expertise in pain. Legendary service. Definitive results. For better quality of life." reinforces its repositioning as the go-to-CRO (Contract Research Organization) for drug discovery and product development.

Unravelling the Ebola virus's biological cycle

Ebola virus infection in humans provokes a violent haemorrhagic fever. It usually flares up as intense epidemics. These kill 80 % of the people infected. Seven such outbreaks have hit Gabon and the Republic of Congo since 1994, leading to 445 cases resulting in 361 deaths.

Added benefit of crizotinib drug for first-line treatment of advanced bronchial carcinoma not proven

The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients with advanced non-small cell lung cancer (bronchial carcinoma) who have a high activity of the enzyme anaplastic lymphoma kinase (ALK) and have already received another treatment. In November 2015, the approval was extended to first-line treatment.

Read more Medical News

› Verified 5 days ago